The comparator sourcing industry has doubled over the past five years, with the need for secure and transparent sourcing of comparator and non-investigational medicinal products (NIMPs) expected to continue to rise, globally.
Most drug candidates are studied against the existing standard of care (comparator), but obtaining these products is a complex process, with supply chain design adding to the challenge. Unoptimised supply chains result in extensive wastage, or a lack of supply at the site which could delay studies and put patients at risk.
The goal is to secure a steady supply of comparator medication throughout the duration of the trial, against the usual constraints of tight timeframes, budgets, and limited supply of competitor products. The globalisation of studies, as well as emerging challenges in international trading and cross-border regulations and availability, only increases the complexity. Add the supply chain disruptions as a result of COVID-19, and it’s evident why clinical trial sourcing is often considered a complicated and expensive part of a study.
However, with the right global sourcing strategies you can optimise cost and supply, even against the background of a clinical trial industry increasing in complexity. Join our webinar to discuss actionable steps for your sourcing strategy to ensure your trial remains in budget and progresses according to expected timelines.
Key Learning Objectives
- Understand comparator sourcing landscape and emerging challenges because of trial globalisation and the impact of COVID-19
- Discover how to optimise your sourcing strategy to ensure cost-effective, predictable supply of comparator products
- Learn how developing an optimised global sourcing strategy, early on in protocol design, can impact a trial’s overall chance of success
Target Audience
- Clinical Investigator
- Heads of Sourcing and Procurement
- Head of Clinical Operations
